|
Main
- Home
- Strategy
- Location
- Jobs
- Facilities
- Internal 
Groups
- Molecular Oncology
- Translational Oncology
- Tumour Biology
- Medical Oncology
- Skin Tumour
- Epidemiology, Mathematics & Statistics
- Nuclear Medicine
Associated
Bodies
- Cancer Research
UK
- Queen Mary University of London
- Queen Mary School
of Medicine & Dentistry
- Barts
& The London NHS Trust
|
Molecular Oncology
Head: Professor Nick Lemoine
Molecular Oncology
Cancer Research UK
Barts and The London School of Medicine and Dentristy
John Vane Science Centre
Charterhouse Square
London EC1M 6BQ
Telephone +44 (0) 20 7014 0420
Fax +44 (0) 20 7014 0431
For directions to the John Vane Science Centre on the Charterhouse site,
click here.
Molecular Oncology Centre
The Molecular Oncology Unit – led by Professor Nick Lemoine
and rated at 5* in the 2001 RAE - seeks to develop innovative therapeutic
and diagnostic approaches to cancer. There are five laboratory teams linked
to the clinic through our clinical fellowship programme and honorary consultants.
It is an internationally recognised centre of expertise in gene therapy
for cancer with an active programme of clinical trials. More details of the work done by the unit can be found Institute of Cancer's web pages at the Barts and
The London, Queen Mary's School of Medicine and Dentistry.
Molecular Oncology Group
(Prof Nick Lemoine, Prof Iain McNeish)
- Aims to develop gene-targeted intervention strategies to treat cancer
using oncolytic viruses and genetic triggers of apoptosis.
Molecular Pathology Group
(Prof Nick Lemoine)
- Aims to generate a complete understanding of the pathogenesis of
pancreatic cancer through molecular and genomic approaches.
Gene Transcription Group
(Prof Helen Hurst)
- Aims to understanding the molecular mechanisms that control expression
of key breast tumour genes, in order to identify novel targets for
cancer therapy.
Molecular Therapy Group
(Dr Daniel Öberg)
- Aims to develop the next generation of gene delivery vectors and
targeting devices in preclinical studies, with special focus on molecular
imaging technology.
Cell Survival Signalling Group
(Dr Subham Basu)
- Aims to understand signal transductions pathways responsible for
both tumorigenesis and the resistance of tumour cells to cytotoxic
and other apoptotic agents.
|
